NEW YORK--(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that it has been awarded $733,000 in funding under the U.S. Government’s Qualifying Therapeutic Discovery Project (QTDP) program.
NEW YORK--(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that it has been awarded $733,000 in funding under the U.S. Government’s Qualifying Therapeutic Discovery Project (QTDP) program.
